These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 798192)

  • 1. Gemfibrozil--a new lipid lowering agent.
    Hodges RM
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):1-2. PubMed ID: 798192
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemfibrozil--a new lipid lowering agent.
    Nash DT
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemfibrozil: a new lipid lowering agent. Open forum.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):115-20. PubMed ID: 1019151
    [No Abstract]   [Full Text] [Related]  

  • 4. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure/activity relationship of gemfibrozil (CI-719) and related compounds.
    Creger PL; Moersch GW; Neuklis WA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):3-5. PubMed ID: 1019152
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of gemfibrozil in vitro on fat-mobilizing lipolysis in human adipose tissue.
    Carlson LA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):101-3. PubMed ID: 1019147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
    Rodney G; Uhlendorf P; Maxwell RE
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
    [No Abstract]   [Full Text] [Related]  

  • 9. Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.
    Hall MJ; Nelson LM; Russell RI; Howard AN
    Atherosclerosis; 1981 Jul; 39(4):511-6. PubMed ID: 6942844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
    Vessby B; Lithell H; Boberg J; Hellsing K; Werner I
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER; Sutherland WH; Temple Wa
    N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC).
    Børresen AL; Berg K; Dahlén G; Gillnäs T; Ericson C
    Artery; 1981; 9(1):77-86. PubMed ID: 7018466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gemfibrozil on lipolysis in dogs in vivo.
    Riemersma RA; Oliver MF
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):107-8. PubMed ID: 1019148
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of CI-719 on lipolysis in rat adipose tissue.
    Elkeles RS; Ashwell M; Priest R; Durrant M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):98-100. PubMed ID: 1019159
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of gemfibrozil.
    Okerholm RA; Keeley FJ; Peterson FE; Glazko AJ
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):11-4. PubMed ID: 828261
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary observations on the effect of gemfibrozil on the excretion of faecal bile acids.
    Baird IM; Lewis B; Hill JM
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):112-4. PubMed ID: 1019150
    [No Abstract]   [Full Text] [Related]  

  • 18. Toleration and bioavailability of gemfibrozil in healthy men.
    Smith TC
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):24-7. PubMed ID: 798193
    [No Abstract]   [Full Text] [Related]  

  • 19. The evaluation of lipoprotein changes during gemfibrozil treatment.
    Janus ED; Costa D; Ononogbu IC; Lewis B
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrinsic factors affecting the response to gemfibrozil.
    Huunan-Seppälä A; Manninen V; Burton R; Eisalo A
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):53-7. PubMed ID: 1019154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.